Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics

T Date, V Nimbalkar, J Kamat, A Mittal… - Journal of controlled …, 2018 - Elsevier
Cancer remained a major cause of death providing diversified challenges in terms of
treatment including non-specific toxicity, chemoresistance and relapse. Nanotechnology …
被引用次数：135 相关文章

Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics

T Date, V Nimbalkar, J Kamat, A Mittal… - Journal of …, 2018 - experts.nebraska.edu
Cancer remained a major cause of death providing diversified challenges in terms of
treatment including non-specific toxicity, chemoresistance and relapse. Nanotechnology …

Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics

T Date, V Nimbalkar, J Kamat… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Cancer remained a major cause of death providing diversified challenges in terms of
treatment including non-specific toxicity, chemoresistance and relapse. Nanotechnology …

[引用][C] Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics

T Date, V Nimbalkar, J Kamat, A Mittal… - Journal of Controlled …, 2018 - cir.nii.ac.jp
Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.

V Nimbalkar, J Kamat, A Mittal, RI Mahato… - Journal of Controlled …, 2017 - europepmc.org
Cancer remained a major cause of death providing diversified challenges in terms of
treatment including non-specific toxicity, chemoresistance and relapse. Nanotechnology …